Locations:
Search IconSearch

Ophthalmology

23-EYE-4003565-Glaucoma-Treatment-CQD (1)

Goniotomy and GATT Aren’t Just for Mild to Moderate Glaucoma

Minimally invasive surgery is effective for uveitic and steroid-induced glaucoma too

23-EYE-3929961-OCTA-in-DR-and-AMD-Hero

5 Practical Uses for OCT-A in AMD and Diabetic Retinopathy

Why retina specialists should get comfortable with this imaging tool

23-EYE-3749863-Retinoblastoma-Podcast-CQD-2
May 11, 2023/Cancer

Retinoblastoma: When Eyeshine Indicates Something Serious (Podcast)

Leukocoria is the most common symptom of this rare childhood eye cancer

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-EYE-3438365 CQD-Fluid volatility in nAMD-Ehlers

Exudative Stability Key to Anti-VEGF Outcome in nAMD

Advanced OCT features may help individualize treatment intervals

22-EYE-3438364 CQD _ OCT-based imaging biomarkers650x450

Unlocking Precision Medicine in RVO: When Anti-VEGF Therapy Isn’t Effective

Intraretinal fluid volumes and other features detectable with OCT may help predict treatment response

23-EYE-3521610 CQD-Time to resolution of DME-Talcott-650×450
February 8, 2023/Diabetes & Endocrinology

Diabetic Macular Edema Can Take 1-2 Years to Resolve in Patients Despite Aggressive Treatment

Greater central subfield thickness and better visual acuity at baseline are associated with longer time to resolution

BackPage 5 of 15Next

Advertisement

Ad